Publications by authors named "Sarah Rippy"

Claim this Profile
P
Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma.
Heather L Gardner, Sarah B Rippy, Misty D Bear, Kim L Cronin, Heather Heeb

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells.
Cheryl A London, Heather L Gardner, Sarah Rippy, Gerald Post, Krista La Perle

Clin Cancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma.
Sarah B Rippy, Heather L Gardner, Sandra M Nguyen, Emma E Warry, Roberta F Portela

BMC Vet Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma.
Sarah B Rippy, Heather L Gardner, Sandra M Nguyen, Emma E Warry, Roberta A Portela

BMC Vet Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis